US Patent Issued to AC Immune, Genentech on Dec. 2 for "Anti-tau antibodies and methods of use" (American, Swiss Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,319, issued on Dec. 2, was assigned to AC Immune SA (Lausanne, Switzerland) and Genentech Inc. (South San Francisco, Calif.).

"Anti-tau antibodies and methods of use" was invented by Oskar Adolfsson (Bercher, Switzerland), Gai Ayalon (Moraga, Calif.), Isidro Hotzel (Brisbane, Calif.) and Danielle Marie Di Cara (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides anti-Tau antibodies and methods of using the same."

The patent was filed on Dec. 13, 2022, under Application No. 18/065,472.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...